Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
Clinical trial NCT02491073 · COMPLETED
Trial details
- NCT number
- NCT02491073
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.